Morgan Stanley Molecular Partners Ag Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Molecular Partners Ag stock. As of the latest transaction made, Morgan Stanley holds 367 shares of MOLN stock, worth $1,801. This represents 0.0% of its overall portfolio holdings.
Number of Shares
367
Previous 500
26.6%
Holding current value
$1,801
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MOLN
# of Institutions
6Shares Held
3.58MCall Options Held
0Put Options Held
0-
Suvretta Capital Management, LLC New York, NY2.22MShares$10.9 Million0.44% of portfolio
-
Bvf Inc San Francisco, CA1.35MShares$6.65 Million0.24% of portfolio
-
Ubs Group Ag6.87KShares$33,7410.0% of portfolio
-
Rhumbline Advisers Boston, MA269Shares$1,3200.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $160M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...